TickerFacts.

Company research / LQDA

Liquidia Corp (LQDA)

Build a valuation ↗↓ Download CSV

CIK 0001819576 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Liquidia Corp reported revenue of $158.32M. Over the twelve months to 2026-06-30, revenue was $450.91M.

Key ratios (year ended 2025-12-31)

-32.5%
Operating margin
-43.5%
Net margin
-154.0%
Return on year-end equity
n/m
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$450.91M$158.32M$14.00M$17.49M$15.94M$12.85M$739.6K$8.07M
Cost of Revenuen/an/a$5.88M$2.89M$2.86M$3.02M$237.7Kn/a
Gross Profit (computed)n/an/a$8.12M$14.60M$13.08M$9.83M$501.9Kn/a
R&D Expense$56.04M$39.28M$47.84M$43.24M$19.43M$20.52M$32.22M$40.49M
Operating Income$168.57M-$51.38M-$121.29M-$73.38M-$38.77M-$33.80M-$59.09M-$46.82M
Depreciation & Amortization$1.69M$1.53M$2.20M$2.18M$3.65M$5.61M$3.13M$2.57M
EBITDA$170.27M-$49.85M-$119.10M-$71.21M-$35.12M-$28.18M-$55.96M-$44.26M
Net Income$138.61M-$68.92M-$128.29M-$78.50M-$41.02M-$34.58M-$59.76M-$47.58M
EPS (Diluted)n/a-$0.80-$1.63-$1.21-$0.67-$0.70-$1.76-$2.57
Total Assets$521.92M$327.93M$230.31M$118.33M$129.20M$93.73M$99.53M$68.84M
Total Liabilities$326.80M$283.19M$150.94M$71.04M$38.78M$28.46M$28.45M$33.89M
Long-Term Debtn/an/an/an/a$19.88M$10.41Mn/an/a
Shareholders' Equity$195.11M$44.75M$79.38M$47.29M$90.42M$65.27M$71.09M$34.95M
Cash & Equivalents$284.18M$190.68M$176.48M$83.68M$93.28M$57.49M$65.32Mn/a
Operating Cash Flow$167.71M-$35.69M-$93.42M-$41.56M-$28.59M-$34.03M-$54.14M-$48.28M
Capital Expenditures$17.01M$4.34M$4.95M$1.29M$592.0K$107.0K$752.1K$1.85M
Free Cash Flow$150.69M-$40.02M-$98.37M-$42.85M-$29.18M-$34.14M-$54.90M-$50.13M
Shares Outstanding89.10M87.20M84.68M68.63M64.52M52.29M43.34M28.23M
Weighted Average Diluted Sharesn/a86.06M78.71M64.99M60.96M49.68M33.89M18.48M
EPS (Basic)n/a-$0.80-$1.63-$1.21-$0.67-$0.70-$1.76n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView